Urologic oncology concerns the surgical treatment of malignant genitourinary diseases such as cancer of the prostate, adrenal glands, bladder, kidneys, ureters, testicles, and penis. The Urologic Oncology Branch conducts clinical and basic research designed to develop better methods for detecting, preventing, and treating patients with kidney cancer, prostate cancer, and bladder cancer. We evaluate and manage patients with non-inherited as well as inherited forms of kidney cancer. The Branch also has an expanding prostate cancer program.
Patients with known or suspected localized and locally advanced prostate cancer undergo advanced MRI imaging followed by fusion image-guided biopsy to diagnose and characterize cancer. They may then be managed with robotic surgery or be followed with active surveillance and intermittent imaging. In addition, we have a growing program in genomics and targeted therapy for bladder cancer patients, including therapy that targets EGFR, FGFR3 and other mutated bladder cancer genes.
Related Journals of Urologic Oncology
Medical & Surgical Urology, Archives of Surgical Urology, Current Trends of Gynecologic Oncology, Integrative Oncology, Oncology Translational Research, Pediatric Oncology: Open Access, Medical Case Reports, Urologic Oncology, Urology Oncology: Seminars and Original Investigations, Current Opinion in Urology, Prostate Cancer and Prostatic Disease, Research and Reports in Urology
